Skip to main content
Clinical Trials/NCT03339180
NCT03339180
Active, not recruiting
Not Applicable

Prevalence and Prognostic Implications of Cardiac Injury in Patients With Influenza-like Illness

Örebro University, Sweden1 site in 1 country466 target enrollmentOctober 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Influenza, Human
Sponsor
Örebro University, Sweden
Enrollment
466
Locations
1
Primary Endpoint
Level of biochemical markers
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

This study investigate the prevalence of elevated biomarkers of cardiac injury in patients with suspected influenza infection and the prognostic implication on the composite endpoint of death of any cause, hospitalization due to myocardial infarction, unstable angina, heart failure and stroke.

Detailed Description

The relationship between influenza and cardiovascular events was described in an early study of influenza epidemics from 1915 to 1929 including the 1918-1920 pandemic. Retrospective studies have shown increased risk for acute myocardial infarction (AMI) during the first week following an infection with influenza. Biochemical markers of cardiac injury such as high sensitive cardiac troponins may be increased during infection with influenza. Increased levels of cardiac troponins are associated with adverse outcome in many different populations.

Registry
clinicaltrials.gov
Start Date
October 1, 2017
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Örebro University, Sweden
Responsible Party
Principal Investigator
Principal Investigator

Anna Nordenskjöld

Principal Investigator

Örebro University, Sweden

Eligibility Criteria

Inclusion Criteria

  • Adult patients (\>18 years) presenting with influenza-like illness.
  • Written informed consent.

Exclusion Criteria

  • Inability to provide informed consent.
  • Age \<18 years.
  • Symptoms indicating an acute coronary syndrome, acute heart failure, rapid atrial fibrillation or acute stroke.

Outcomes

Primary Outcomes

Level of biochemical markers

Time Frame: One year

Level of other biochemical markers in patients with influenza

Secondary Outcomes

  • Prognostic implication(One year)

Study Sites (1)

Loading locations...

Similar Trials